Syndax Pharmaceuticals Inc (SNDX)
22.05
+0.19
(+0.87%)
USD |
NASDAQ |
May 03, 16:00
22.04
0.00 (0.00%)
After-Hours: 20:00
Syndax Pharmaceuticals Cash from Investing (Quarterly): -16.29M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -16.29M |
| September 30, 2023 | 40.08M |
| June 30, 2023 | 73.91M |
| March 31, 2023 | 19.92M |
| December 31, 2022 | -137.63M |
| September 30, 2022 | -6.793M |
| June 30, 2022 | -49.95M |
| March 31, 2022 | 8.182M |
| December 31, 2021 | -59.96M |
| September 30, 2021 | 26.63M |
| June 30, 2021 | 21.68M |
| March 31, 2021 | -29.23M |
| December 31, 2020 | -64.14M |
| September 30, 2020 | 19.28M |
| June 30, 2020 | -78.61M |
| March 31, 2020 | -19.05M |
| December 31, 2019 | 6.596M |
| September 30, 2019 | 12.36M |
| June 30, 2019 | -18.93M |
| March 31, 2019 | 12.75M |
| December 31, 2018 | 15.96M |
| September 30, 2018 | 3.508M |
| Date | Value |
|---|---|
| June 30, 2018 | 19.28M |
| March 31, 2018 | 12.64M |
| December 31, 2017 | 1.55M |
| September 30, 2017 | 6.92M |
| June 30, 2017 | -36.56M |
| March 31, 2017 | 11.01M |
| December 31, 2016 | 21.43M |
| September 30, 2016 | 8.05M |
| June 30, 2016 | -0.624M |
| March 31, 2016 | -47.14M |
| December 31, 2015 | -17.56M |
| September 30, 2015 | -7.413M |
| June 30, 2015 | -17.21M |
| March 31, 2015 | -19.48M |
| December 31, 2014 | -2.10M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 2.536M |
| March 31, 2014 | 1.452M |
| December 31, 2013 | -4.052M |
| September 30, 2013 | -0.008M |
| June 30, 2013 | 0.033M |
| March 31, 2013 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-137.63M
Minimum
Dec 2022
73.91M
Maximum
Jun 2023
-13.26M
Average
-6.793M
Median
Sep 2022
Cash from Investing (Quarterly) Benchmarks
| SpringWorks Therapeutics Inc | 21.46M |
| Alnylam Pharmaceuticals Inc | -67.62M |
| Geron Corp | 34.21M |
| Ionis Pharmaceuticals Inc | -26.71M |
| Madrigal Pharmaceuticals Inc | -362.12M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -41.35M |
| Cash from Financing (Quarterly) | 258.48M |
| Free Cash Flow | -160.60M |
| Free Cash Flow Per Share (Quarterly) | -0.57 |
| Free Cash Flow Yield | -10.35% |